Status: Enrolling
Investigator: Kirk Heyne
Study Coordinator: Pej Hemati
Phone: 713.441.3926
This is a multicenter Phase 1b, open-label study to assess safety, tolerability, preliminary efficacy, and pharmacokinetics (PK) of cabozantinib taken in combination with atezolizumab in subjects with multiple tumor types, including advanced uro ... Read more >
